Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression

SIMPLE SUMMARY: Anti-PD1 therapy appears as one of the most promising anticancer therapy of recent years. Almost all patients will develop resistance over time. In this context, we have sought to identify resistant patients, in order to be able to propose a therapeutic solution. Our study has identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bougras-Cartron, Gwenola, Nadaradjane, Arulraj, Joalland, Marie-Pierre, Lalier-Bretaudeau, Lisenn, Raimbourg, Judith, Cartron, Pierre-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296663/
https://www.ncbi.nlm.nih.gov/pubmed/37370798
http://dx.doi.org/10.3390/cancers15123188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296663/
https://www.ncbi.nlm.nih.gov/pubmed/37370798
http://dx.doi.org/10.3390/cancers15123188

Ejemplares similares